Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently submitted to: Journal of Medical Internet Research

Date Submitted: Apr 11, 2026
Open Peer Review Period: Apr 14, 2026 - Jun 9, 2026
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).

Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Artificial Intelligence Application in Public Health Emergencies Arising from Infectious Hazards: A Scoping Review

  • Sara Abu Khudair; 
  • Laura Espinosa; 
  • Gianfranco Spiteri; 
  • Yousef Khader; 
  • Thomas Mollet; 
  • David Novillo Ortiz; 
  • Sevil Huseynova; 
  • Jawameer Kakakhan

ABSTRACT

Background:

Artificial Intelligence (AI) methods offer a valuable complementary approach to public health emergency management, supporting prediction, rapid threat identification, and timely decision-making alongside the already established human-led systems and processes. However, updated and comprehensive evidence on the extent and characteristics of AI use in public health emergencies, with a specific focus on infectious hazards, remains limited globally.

Objective:

This review aimed to map the scope, nature, and extent of AI applications in public health emergency management resulting from infectious hazards, and to characterize key implementation features.

Methods:

A scoping review was conducted following the Arksey and O’Malley framework, and a search was performed in three electronic databases, including PubMed, Scopus, and the IEEE Xplore Digital Library. The search period covered studies published between January 2014 and June 2024.

Results:

A total of 613 studies were included, of which 526 (85.8%) were AI-related methodological studies and 87 (14.2%) were reviews or other article types. Across these studies, 665 infectious-hazard records were extracted, with COVID-19 accounting for the majority (387, 58.2%), followed by influenza (8.4%), dengue (4.1%), and malaria (3.0%). Publications increased steadily from 2014 to mid-2024, with a sharp rise beginning in 2019 and peaking in 2022, aligning with the COVID-19 pandemic. Notably, studies on non–COVID-19 hazards also grew between 2019 and 2023, suggesting expanding AI applications. Among methodological studies, 31.4% used social media data, mainly from X (formerly Twitter) and Weibo. Most focused on predictive analytics and disease surveillance (58.2%), followed by risk communication (23.2%), compliance with public health measures (12.5%), and policy evaluation (6.1%). Data were predominantly sourced from the USA (12.1%) and China (10.5%), with limited representation from Africa, Central Asia, and the Middle East. Funding was mainly reported from organizations in China (14.4%) and the USA (14.1%), followed by Saudi Arabia and South Korea.

Conclusions:

The findings indicate that applications of AI in infectious disease emergencies are predominantly focused on predictive modeling and surveillance, with a considerable reliance on social media data. The United States and China emerge as the primary contributors, both as sources of data and as leading funders of this research. To promote more equitable and effective use of AI in public health emergencies, there is a critical need for increased investment in local expertise, data infrastructure, and operational capacity, particularly in low- and middle-income countries.


 Citation

Please cite as:

Abu Khudair S, Espinosa L, Spiteri G, Khader Y, Mollet T, Novillo Ortiz D, Huseynova S, Kakakhan J

Artificial Intelligence Application in Public Health Emergencies Arising from Infectious Hazards: A Scoping Review

JMIR Preprints. 11/04/2026:97132

DOI: 10.2196/preprints.97132

URL: https://preprints.jmir.org/preprint/97132

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.